Interaction and Antiviral Treatment of Coinfection between SARS-CoV-2 and Influenza in Vitro

CONCLUSIONS: In coinfection, the replication of SARS-CoV-2 would be interfered by influenza H1N1. Compared with molnupiravir or baloxavir monotherapy, treatment with a combination of molnupiravir and baloxavir should be considered for early treatment in patients with SARS-CoV-2 and influenza coinfection.PMID:38621598 | DOI:10.1016/j.virusres.2024.199371
Source: Cell Research - Category: Cytology Authors: Source Type: research